Fiscal Year 2016


  1. Sawai THatta TFujita M. Public attitudes in Japan towards human-animal chimeric embryo research using human induced pluripotent stem cells. Regenerative Medicine. DOI: 10.2217/rme-2016-0171.
  2. Takashima K, Takimoto Y, Nakazawa E, Hayashi Y, Tsuchiya A, Fujita M, Akabayashi A. Discovery and informing study participants of incidental findings detected in brain magnetic resonance imaging studies: review and multi-institutional study. Brain and Behavior. 2017; DOI: 10.1002/brb3.676.
  3. Ema A, Akiya N, Osawa H, Hattori H, Oie S, Ichise R, Kanzaki N, Kukita M, Saijo R, Otani T, Miyano N, Yashiro Y. Future relations between humans and artificial intelligence: a stakeholder opinion survey in Japan-. IEEE Technology and Society Magazine. 2016; 35(4): 68-75. DOI: 10.1109/MTS.2016.2618719.
  4. Sawai TFujita M. The Problem of Dual Use in Relation to Decoded Neurofeedback. AJOB Neuroscience. 2016; 7(4): 253-254. DOI: 10.1080/21507740.2016.1244126.
  5. Suzuki M, Sato K. Description and Evaluation of the Research Ethics Review Process in Japan: Proposed Measures for Improvement. Journal of Empirical Research on Human Research Ethics. 2016; 11(3): 256-266. DOI: 10.1177/15562646|6660644.
  6. Inoue Y, Shineha R, Yashiro Y. Current public support for human-animal chimera research in Japan is limited despite high levels of scientific approval. Cell Stem Cell. 2016. DOI: 10.1016/j.stem.2016.07.011.
  7. Kashihara H, Nakayama T, Hatta T, Takahashi N, Fujita M. Evaluating the quality of website information on private-practice clinics offering cell therapies in Japan. interactive Journal of Medical Research. 2016; 5(2):e15. DOI: 10.2196/ijmr.5479.